Tel: 020 7405 1222 or email

Patents

11 South Square has a rich pedigree in patent disputes.  We offer extensive experience and expertise in all aspects of patent and Supplementary Protection Certificate prosecution and enforcement. In addition to infringement, revocation and entitlement actions in the English courts, members of chambers act in proceedings in the European Patent Office and the UK Intellectual Property Office.  We regularly appear in high value, multi-jurisdictional patent actions involving complex subject matter and elements of competition law. Some members of chambers have appeared as experts on UK patent law in other jurisdictions.

All members of chambers accept patent cases in all technical fields; some individuals have particular strengths in certain technologies such as biotechnology, chemistry or electronics and telecommunications. Further information on the special expertise of individual members of Chambers is available from the clerks.

 

Notable Cases

Samsung v Apple [2013] EWHC 468 (Pat) and [2013] EWHC 467 (Pat)

Samsung v Apple [2013] EWHC 468 (Pat) and [2013] EWHC 467 (Pat)

Dispute in which Samsung made a claim against Apple for infringement of three patents relating to mobile phones/tablet computers.  The trial was divided into two halves to deal with the patents and was heard in the Patents Court in November and December 2012.

Samsung v Apple [2013] EWHC 467 (Pat) and [2013] EWHC 468 (Pat)

Virgin Atlantic Airways Ltd v Contour Aerospace & ors [2012] EWHC 2153 (Pat)

Virgin Atlantic Airways Ltd v Contour Aerospace & ors [2012] EWHC 2153 (Pat)

Patent infringement and validity trial in June-July 2012 in this long running dispute over aircraft seats. Iain acted for the successful Defendants.

Virgin Atlantic Airways Ltd v Contour Aerospace & ors [2012] EWHC 2153 (Pat)

Glenmark Generics (Europe) Ltd & Anor (t/a Mylan) v The Wellcome Foundation Ltd & Anor [2013] EWHC 148 (Pat)

Glenmark Generics (Europe) Ltd & Anor (t/a Mylan) v The Wellcome Foundation Ltd & Anor [2013] EWHC 148 (Pat)

Claim for revocation of a drug combination patent (atovaquone and proguanil sold as the antimalarial Malarone).  Use of the combination in clinical trials had been disclosed before the priority date.  The patentee argued that the skilled person would disregard this disclosure.  Arnold J rejected this argument and revoked the patent for lack of inventive step

Glenmark Generics (Europe) Ltd & Anor (t/a Mylan) v The Wellcome Foundation Ltd & Anor [2013] EWHC 148 (Pat)